BBMRI.QM Web Conference | BBMRI-ERIC: Making New Treatments Possible
FontsA A
ContrastA A
Newsletter sign-up
I give permission for BBMRI-ERIC to send me their newsletter and emails about subjects which they think may be of interest to me. I can unsubscribe from all emails at any time. I understand that my information will be processed according to BBMRI-ERIC's privacy notice.

BBMRI.QM Web Conference

Web conference #2 took place on 7 April 2020:

Biobanking in times of COVID-19,

Pre-analytical procedures

 

Aim and Agenda

Follow this link

Recording

Follow this link

Presentations

Lukasz Kozera – Pre-analytical phase for COVID-19 samples

Antonio di Caro – BBMRI Webinar Biosafety

Helmuth Haslacher – BBMRI COVID-19

Andrea Wutte – BBMRI-ERIC Webcon COVID-19 #2

 

Web conference #1 took place on 1 April 2020:

Biobanking in Times of COVID-19,

Risks and Opportunities for Biobanks

 

Aim and Agenda

Follow this link

Recording

Follow this link

Presentations

Petr Holub – BBMRI-ERIC Directory and Negotiator for COVID

Maurice Bardsley – EVAg BBMRI COVID19

Andrea Ganna – COVID-19 Rapid Global Reset Response Genetics Initiative

Q&A to webinars

Questions and Answers – WebCon #1, #2

Documents and relevant links

 

ISO

20387:2018 Biotechnology — Biobanking — General requirements for biobanking

15190:2020 Medical laboratories — Requirements for safety

15189:2012 Medical laboratories — Requirements for quality and competence

WHO

Laboratory biosafety guidance related to coronavirus disease (‎COVID-19)‎: interim guidance, 19 March 2020

Laboratory testing for coronavirus disease (‎‎COVID-19)‎‎ in suspected human cases: interim guidance, 19 March 2020

Laboratory testing of human suspected cases of novel coronavirus (‎‎‎‎‎‎‎‎nCoV)‎‎‎‎‎‎‎‎ infection: interim guidance, 10 January 2020

Guidance for laboratories shipping specimens to WHO reference laboratories that provide confirmatory testing for COVID-19 virus: interim guidance, 2 March 2020

CDC/USA

Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 (COVID-19)

Interim Laboratory Biosafety Guidelines for Handling and Processing Specimens Associated with Coronavirus Disease 2019 (COVID-19)

ZHEIJANG UNIVERSITY SCHOOL OF MEDICINE/CHINA

Handbook of COVID-19 Prevention and Treatment

UCSF/USA

– UCSF Guidelines for Research Biospecimens during the COVID-19 Outbreak

 

If you need more information, please contact our BBMRI.QM team:

 

Andrea Wutte / Quality Management andrea.wutte@bbmri-eric.eu

Daniela Krasser / Quality Management Officer daniela.krasser@bbmri-eric.eu

Nadja Palko / QM Service Officer nadja.palko@bbmri-eric.eu

Joanna Vella / Quality Management Officer joanna.vella@bbmri-eric.eu

 


The website was co-funded within ADOPT BBMRI-ERIC, a project that has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 676550.
We use cookies to analyse the traffic on our websites. All personal data is anonymized and not shared with third parties! Click here for more information.
Accept